NKGen Biotech Announces the Appointment of Philip Moody as Chief Financial Officer

NKGen Biotech Announces the Appointment of Philip Moody as Chief Financial Officer

NKGen Biotech is a clinical stage biotechnology company dedicated to restoring and enhancing overall immune integrity. Our proprietary natural killer cell expansion and activation technology achieves infinite fold natural killer cell expansion with greatly enhanced cytotoxicity across both autologous and allogenic products which are all derived from peripheral blood. Our first in class autologous product, SNK01, is currently in a Phase I clinical trial in advanced refractory solid tumors and in a Phase I/IIa combination trial with pembrolizumab in Stage IV non-small cell lung cancer. We have also added another cohort of SNK01 in combination with pembrolizumab or avelumab in refractive PD-L1 positive or PD-L1 negative solid tumors and are planning to initiate a Phase 1 combination trial of SNK01 and AFM24 in EGFR positive solid tumors. The company and its commercially licensed cGMP facility are headquartered in Santa Ana, California, USA. http://www.nkgenbiotech.com/ About NKGen Biotech Contact:Denise Chua, MBA, CLS, MT (ASCP)Vice President, Marketing 949-396-6830dchua@nkgenbiotech.com

Mr. Moody completed a BS in Mechanical Engineering from the University of California, Berkley and studied finance at its Haas Graduate School of News. “NKGen Biotech has a leading NK cell therapy platform and pipeline, along with an impressive manufacturing facility,” said Mr. Moody. ” I believe the potential for growth and value creation is tremendous. It is a great time to be joining the NKGen Biotech team to further align financial strategy with its corporate goals and position the Company for further financings.”

Story continues Mr. Moody has 25 years of broad healthcare and biotech industry leadership experience. He was CFO and Executive Vice President of PaxVax, a private equity-backed specialty vaccine company. Prior to PaxVax, Mr. Moody was CFO, North America for BTG PLC, a publicly traded medical device and specialty pharmaceutical company that was acquired by Boston Scientific. Additionally, he served as CFO and Vice President of Finance and Operations for publicly traded Peplin, Inc., an oncology therapeutics company. Mr. Moody began his biotech career at Chiron Corporation where he progressed through roles of increasing responsibility to the role of CFO and Senior Vice President of Finance and Operations, Biopharmaceuticals.

Source finance.yahoo.com

The News Highlights

  • NKGen Biotech Announces the Appointment of Philip Moody as Chief Financial Officer
  • Check the latest News news updates and information about business, finance and more.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
Man escapes indecent exposure citation from Mocksville police

Man escapes indecent exposure citation from Mocksville police

According to call log documents from Davie County Communications, officers responded to the Kentucky Fried Chicken, on the 1200 block of Yadkinville Road in ...
The Newport Men’s Seaweed Health Product Promotes Human and Ocean Health

The Newport Men’s Seaweed Health Product Promotes Human and Ocean Health

More:Tiverton family opens self-service dog wash in Middletown Seagreen is a powder compound that can be mixed with water, coffee, tea or smoothies. Brown said ...
Sermonix Pharmaceuticals Project With Huntsman Cancer Institute Researcher to Investigate Potential Effects of Lasofoxifene on ESR1 Mutations in Endometrial Cancer

Sermonix Pharmaceuticals Project With Huntsman Cancer Institute Researcher to Investigate Potential Effects of Lasofoxifene on ESR1 Mutations in Endometrial Cancer

News Highlights COLUMBUS, Ohio, April 21, 2021 (News) — Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative ...
Online Community Psychable Partners With Heroic Hearts Project to Launch #NatureHeals, a Social Media Advocacy Campaign to Raise Awareness of the Healing Power of Psychedelics

Online Community Psychable Partners With Heroic Hearts Project to Launch #NatureHeals, a Social Media Advocacy Campaign to Raise Awareness of the Healing Power of Psychedelics

News Highlights LOS ANGELES, April 21, 2021 (News) — Psychable, the online community for people who are interested in legally exploring or offering ...
Binghamton University, SUNY Broome announces partnership between business schools

Binghamton University, SUNY Broome announces partnership between business schools

Source wbng.com SUNY Broome President Kevin Drumm said students will not need to immediately apply to be in the “Two and U” program; instead, students in the ...
The Dunkirk Foundry Agreement provides a window into GFG's complex financing web

Australia plans to spend $ 417 million on hydrogen and carbon capture | World News

Australia is home to the world’s largest carbon capture and storage facility at Chevron’s Gorgon natural gas project on Barrow Island off its northwest coast. ...
New Update on Desktop (PC) Spirometer Market 2021 Analysis

New Update on Desktop (PC) Spirometer Market 2021 Analysis

Additionally, the Desktop (PC) Spirometer Market report also identifies and analyses changing dynamics, emerging trends along with essential drivers, ...
Read the stars and predict the future in the mystical storytelling game ‘Grotto’

Read the stars and predict the future in the mystical storytelling game ‘Grotto’

Grotto will be out on Switch towards the end of this year, some time between August and December. “Their fate will change according to your auguries,” ...
Mike Novogratz’s Digital Galaxy is in talks to buy BitGo Crypto Custodian

Mike Novogratz’s Digital Galaxy is in talks to buy BitGo Crypto Custodian

Galaxy is part of the NYDIG crypto trading consortium alongside the 86-year-old Wall Street institution Morgan Stanley. NYDIG, an emerging player among ...
Show next
Compsmag - Latest News from tech, business and health
Logo